World's Best Scientists 2026 revealed!
Catia Traversari

Catia Traversari

D-Index & Metrics

Immunology

D-Index
61
Citations
22027
World Ranking
3187
National Ranking
122

Catia Traversari publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Catia Traversari sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 169 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Catia Traversari D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Catia Traversari sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Catia Traversari is affiliated with MolMed in Italy and has contributed extensively to research in medicine, particularly within the intersecting fields of biochemistry, genetics, molecular biology, immunology, and microbiology. Their research spans various subfields including oncology, genetics, molecular biology, immunology, and biomedical engineering.

The scientific work of Traversari focuses on key topics such as CAR-T cell therapy research, viral infectious diseases and gene expression in insects, virus-based gene therapy research, nanowire synthesis and applications, cholesterol and lipid metabolism, immune cell function and interaction, as well as immunotherapy and immune responses.

Traversari's recent publications cover a range of study areas and include:

  • "CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice" (2020), published in Frontiers in Immunology
  • "Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer" (2021), published in Human Gene Therapy
  • "Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses" (2023), published in Cell Death and Disease
  • "Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery" (2025), published in Stem Cell Research & Therapy
  • "Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy" (2025), published in Nature Communications

Their frequent collaborators include Simona Porcellini, Claudia Asperti, Stefano Corna, Anna Stornaiuolo, and Barbara Valentinis, each of whom has coauthored multiple papers with Traversari.

Traversari's research has appeared in several distinguished scientific journals, including:

  • Frontiers in Immunology
  • Human Gene Therapy
  • Cell Death and Disease
  • Stem Cell Research & Therapy
  • Nature Communications

Best Publications

  • A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

    P van der Bruggen;C Traversari;P Chomez;C Lurquin

  • HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia

    Chiara Bonini;Giuliana Ferrari;Simona Verzeletti;Paolo Servida

  • Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

    Margherita Norelli;Barbara Camisa;Giulia Barbiera;Laura Falcone

  • A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

    P G Coulie;V Brichard;A Van Pel;T Wölfel

  • Structure, Chromosomal Localization, and Expression of 12 Genes of the Mage Family

    Etienne De Plaen;Etienne De Plaen;Catia Traversari;Catia Traversari;José J.J. Gaforio;José J.J. Gaforio;Jean Pierre Szikora;Jean Pierre Szikora

  • A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

    C Traversari;P van der Bruggen;I F Luescher;C Lurquin

  • HMGB1 is an endogenous immune adjuvant released by necrotic cells

    Patrizia Rovere-Querini;Annalisa Capobianco;Paola Scaffidi;Barbara Valentinis

  • Differentiation of T Regulatory Cells by Immature Dendritic Cells

    Maria Grazia Roncarolo;Megan K. Levings;Catia Traversari

  • A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

    P van der Bruggen;J Bastin;T Gajewski;T Gajewski;P G Coulie

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

  • Tumor-mediated liver X receptor-[alpha] activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

    Eduardo J. Villablanca;Laura Raccosta;Dan Zhou;Raffaella Fontana

  • Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.

    Alfonso Serrano;Silvia Tanzarella;Ilaria Lionello;Rosa Mendez

  • The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.

    Catia Traversari;Sarah Marktel;Zulma Magnani;Patrizia Mangia

  • Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer

    Fulvio Mavilio;Giuliana Ferrari;Silvano Rossini;Nadia Nobili

  • Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes.

    C Traversari;P van der Bruggen;P van der Bruggen;B Van den Eynde;B Van den Eynde;P Hainaut;P Hainaut

  • Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine

    Luca Sigalotti;Elisabetta Fratta;Sandra Coral;Silvia Tanzarella

  • A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

    Daniel C. Thomis;Sarah Marktel;Chiara Bonini;Catia Traversari

  • The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

    Laura Raccosta;Raffaella Fontana;Daniela Maggioni;Claudia Lanterna

  • Transfer of the HSV-tk Gene into Donor Peripheral Blood Lymphocytes for In Vivo Modulation of Donor Anti-Tumor Immunity after Allogeneic Bone Marrow Transplantation. The San Raffaele Hospital, Milan, Italy

    Principal Investigators: Claudio Bordignon;Chiara Bonini;Investigators: Simona Verzeletti;Nadia Nobili

  • Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus-Leukemia: Clinical Follow-up and Improved New Vectors

    Simona Verzeletti;Chiara Bonini;Sarah Marktel;Nadia Nobili

  • A New Gene Coding for a Differentiation Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas By Pierre G. Coulie, Vincent Brichard, Aline Van Pel,

    Thomas W;Jorg Schneider;Catia Traversari;Stes Mattei

Frequent Co-Authors

Claudio Bordignon
Claudio Bordignon MolMed (Italy)
Pierre van der Bruggen
Pierre van der Bruggen Université Catholique de Louvain
Thierry Boon
Thierry Boon Ludwig Cancer Research
Chiara Bonini
Chiara Bonini Vita-Salute San Raffaele University
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Benoît Van den Eynde
Benoît Van den Eynde Ludwig Cancer Research
Pierre Coulie
Pierre Coulie Université Catholique de Louvain
Claudio Doglioni
Claudio Doglioni Vita-Salute San Raffaele University
Luca Vago
Luca Vago Vita-Salute San Raffaele University
Vincenzo Russo
Vincenzo Russo University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in exploring career options beyond immunology, pursuing specialized nursing degrees can be a rewarding path. Programs like the best psychiatric mental health nurse practitioner programs online offer strong clinical placement support, enabling students to gain valuable real-world experience while advancing their education.

Cost is often a key consideration when selecting a program. Prospective students should consider options such as affordable pmhnp programs, which provide quality education without overwhelming financial burdens.

Understanding potential earnings is also essential. Those pursuing a Doctor of Nursing Practice degree can reference data on dnp salary to gauge the financial outlook across different states and specialties.

For current nurse practitioners considering a shift in focus, resources like fnp to acute care np provide guidance on making this transition smoothly, opening doors to acute care settings that align well with immunology expertise.

Best Scientists Citing Catia Traversari

Trending Scientists

Recently Published Articles